Paper3943053
Consistent chromosomal translocation in alveolar rhabdomyosarcoma.
Turc-Carel C and 5 others. Cancer Genet Cytogenet, 1986. Cited by 218 papers, by iCite.
Cite this record
ConductScience Library. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Papers, record 3943053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3943053
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomes, Human, 1-3 | Major topic |
| Chromosomes, Human, 13-15 | Major topic |
| Lung Neoplasms | Major topic |
| Rhabdomyosarcoma | Major topic |
| Translocation, Genetic | Major topic |
| Adult | |
| Humans | |
| Male | |
| Pulmonary Alveoli |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38286829 | Aneuploidy and complex genomic rearrangements in cancer evolution. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38286829 | PubMed |
| 36395771 | PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. | Mol Cell | 2022 | https://conductscience.org/library/papers/36395771 | PubMed |
| 35619911 | No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/35619911 | PubMed |
| 34958505 | Evolving classification of rhabdomyosarcoma. | Histopathology | 2022 | https://conductscience.org/library/papers/34958505 | PubMed |
| 33248210 | Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33248210 | PubMed |
| 30617281 | Rhabdomyosarcoma. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/30617281 | PubMed |
| 29730428 | The expression and function of PAX3 in development and disease. | Gene | 2018 | https://conductscience.org/library/papers/29730428 | PubMed |
| 29404242 | Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach. | J Neurol Surg B Skull Base | 2018 | https://conductscience.org/library/papers/29404242 | PubMed |
| 25912319 | The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma. | Virchows Arch | 2015 | https://conductscience.org/library/papers/25912319 | PubMed |
| 24427371 | Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/24427371 | PubMed |
| 24156028 | Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. | Cancer Med | 2013 | https://conductscience.org/library/papers/24156028 | PubMed |
| 24113309 | Classification of rhabdomyosarcoma and its molecular basis. | Adv Anat Pathol | 2013 | https://conductscience.org/library/papers/24113309 | PubMed |
| 23799156 | Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma. | PLoS One | 2013 | https://conductscience.org/library/papers/23799156 | PubMed |
| 23036318 | Mouse models of sarcomas: critical tools in our understanding of the pathobiology. | Clin Sarcoma Res | 2012 | https://conductscience.org/library/papers/23036318 | PubMed |
| 21917598 | Childhood rhabdomyosarcoma: recent advances and prospective views. | J Dent Res | 2012 | https://conductscience.org/library/papers/21917598 | PubMed |
| 21423212 | Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells. | Oncogene | 2011 | https://conductscience.org/library/papers/21423212 | PubMed |
| 19158934 | Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis. | Int J Clin Exp Pathol | 2009 | https://conductscience.org/library/papers/19158934 | PubMed |
| 18521238 | Molecular alterations in pediatric sarcomas: potential targets for immunotherapy. | Sarcoma | 1998 | https://conductscience.org/library/papers/18521238 | PubMed |
| 18271875 | Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18271875 | PubMed |
| 16964289 | Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain. | Oncogene | 2007 | https://conductscience.org/library/papers/16964289 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3943053
GET https://conductscience.org/api/papers/v1/3943053/cited_by?page=2